4
Changes in Ownership
Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-22-015031
Options or other derivatives
- Director acquired 23,345 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/wf-form4_165307729475114.xml…